Funder: National Institutes of Health
Due Dates: October 21, 2025 (Renewal/Resubmission/Revision) | December 9, 2025 (Current Closing Date)
Funding Amounts: Up to $400,000 in direct costs per year; maximum project period of 2 years; 1:1 non-Federal matching required.
Summary: Supports follow-on clinical research using adult stem cells under the Regenerative Medicine Innovation Project (RMIP) for previously funded RMIP clinical trials.
Key Information: Strict 1:1 non-Federal cost matching is mandatory for all awards.